Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting Big on These Q2 IPOs

Page 1 of 2

The US initial public offering (IPO) market has been rather quiet during the second quarter. Uncertainty related to a potential interest rate increase by the Federal Reserve and to the UK’s Brexit vote have caused companies to delay their IPO plans to the third quarter. Nevertheless, there were a number of companies that decided to proceed despite everything. In this article, we’ll take a look at five post-IPO companies that hedge funds snapped up during the second quarter and see how they have fared since then.

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see more details here).

background, modern, room,

ImageFlow/Shutterstock.com

Bets On Hospital Operator

Opening our top five is Quorum Health Corp (NYSE:QHC). At the end of the quarter, 17 of the funds followed by Insider Monkey had this stock in their equity portfolios, having amassed 30% of the company’s outstanding stock in aggregate. David Einhorn‘s Greenlight Capital had the largest position, having acquired 2.9 million shares worth a little over $31 million according to its latest 13F filing. David Tepper and Appaloosa Management are also betting on this stock, having disclosed ownership of 771,436 shares valued at $8.26 million. A spin-off from Community Health Systems (NYSE:CYH), Quorum Health Corp (NYSE:QHC) owns and operates hospitals. Immediately after the IPO, the stock turned south and is currently down by 52%. For the second quarter, the company posted $529.7 million in revenue and a loss of $8.63 per share.

Follow Quorum Health Corp
Trade (QHC) Now!

High Demand For Ingevity Corp

Next up is Ingevity Corp (NYSE:NGVT), a stock that could be found in the equity portfolio of 19 of the funds in our database. Howard Guberman and Sean Dany‘s Gruss Asset Management made a $40.8 million investment in this company, having reported ownership of exactly 1.2 million shares at the end of the quarter. Noah Levy and Eugene Dozortsev have also established a fresh position for their fund, Newtyn Management, having acquired 1.05 million shares reportedly worth $35.9 million. A manufacturer of specialty chemicals and high-performance carbon materials, Ingevity Corp (NYSE:NGVT) has enjoyed a nice rally since going public, with shares having appreciated by 82% through yesterday’s closing price of $41.95 per share. Analysts at KeyCorp initiated coverage of the stock at the beginning of July and assigned an ‘Overweight’ rating with a price target of $43 per share, which was already surpassed earlier this month. For the second quarter, Ingevity Corp (NYSE:NGVT) reported a 5% decline in net sales to $248.7 million and a profit of $25.8 million or $0.66 per share when adjusted for one-time costs.

Follow Ingevity Corp
Trade (NGVT) Now!

Turn the page to find out which IPOs ranked on the first three spots among the investors we track.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!